Treatment Patterns And Outcomes In Patients Treated With Benefix Or Refacto/Refacto AF - A Swedish Cohort Study

Study Evaluating BDDRFVIII and ReFacto AF in Hemophilia A

NCT00038935 ·Status: COMPLETED ·Phase: PHASE3

Factor Product Utilization and Health Outcomes in Patients With Hemophilia

NCT02796222 ·Status: COMPLETED

Long-Term Safety and Efficacy of rFIXFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia B

NCT01425723 ·Status: COMPLETED ·Phase: PHASE3

Post Marketing Observational Study of Reformulated BeneFIX

NCT00835068 ·Status: COMPLETED

Patient-reported Outcomes in Subjects Treated With ReFacto AF Routine Prophylaxis

NCT02718677 ·Status: WITHDRAWN

Post Marketing Surveillance To Observe Safety and Efficacy Of BeneFIX In Patients With Hemophilia B

NCT00484185 ·Status: COMPLETED

Study Evaluating BeneFIX in Patients With Haemophilia B, Previously Treated With Plasma Derived Factor IX

NCT00749476 ·Status: COMPLETED ·Phase: PHASE4

Study Comparing On-Demand Treatment With Two Prophylaxis Regimens Of BeneFIX In Patients With Severe Hemophilia B

NCT00364182 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating of Recombinant Human Factor IX (BeneFIX) and a New Formulation of BeneFIX (rFIX-R) in Moderate to Severe Hemophilia B

NCT00093210 ·Status: COMPLETED ·Phase: PHASE3

An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B

NCT06008938 ·Status: RECRUITING

Study Evaluating "Real World" Treatment Pattern in Previously Treated Hemophilia A Patients Receiving KOVALTRY (Octocog Alfa) for Routine Prophylaxis

NCT02830477 ·Status: COMPLETED

Registry For Patients Treated With BeneFix In Usual Care Setting In Germany

NCT00714415 ·Status: COMPLETED

Study of Recombinant Factor IX Fc Fusion Protein (rFIXFc) in Participants With Hemophilia B

NCT01027364 ·Status: COMPLETED ·Phase: PHASE3

Dose-escalation Study to Investigate the Safety, PK, and PD of ISU304/CB2679d in Hemophilia B Patients

NCT03186677 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of Benefix in Patients With Hemophilia B in Usual Care Settings in China

NCT02336178 ·Status: COMPLETED ·Phase: PHASE4

An Open-Label, Single Dose Pharmacokinetic Study of Benefix (Recombinant Factor IX) in Male Chinese Subjects With Hemophilia B

NCT02213250 ·Status: COMPLETED ·Phase: PHASE1

Prospective Registry of European Hemophilia B Patients Receiving BeneFIX® for Usual Use

NCT00167973 ·Status: COMPLETED

Study to Determine the Safety and Efficacy of rFIXFc in Previously Untreated Males With Severe Hemophilia B

NCT02234310 ·Status: COMPLETED ·Phase: PHASE3

Study To Compare On-Demand Treatment To A Prophylaxis Regimen Of BeneFIX In Subjects With Moderately Severe to Severe Hemophilia B

NCT01335061 ·Status: COMPLETED ·Phase: PHASE3

Fc factOrs and Real-World hemophiliA Patient-ReporteD Outcomes

NCT02392156 ·Status: TERMINATED

Efficacy and Safety of AlphaNine Versus BeneFIX in Patients With Severe Hereditary Haemophilia B

NCT03091751 ·Status: COMPLETED ·Phase: PHASE2

PF-06741086 Long-term Treatment in Severe Hemophilia

NCT03363321 ·Status: COMPLETED ·Phase: PHASE2

Understanding Hemophilia A and B Drug Dosage Administration Patterns

NCT03248141 ·Status: TERMINATED

Evaluation of the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Patients With Severe Hemophilia A

NCT00782470 ·Status: COMPLETED

A Non-interventional Retrospective Study of the Current Treatment Practice in European Haemophilia Care

NCT02049099 ·Status: COMPLETED